for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Merck quarterly profit rises nearly 55% as key drug sales rebound

Oct 27 (Reuters) - Merck & Co Inc on Tuesday reported a 54.7% rise in third-quarter profit, helped by strong sales of blockbuster cancer drug Keytruda and rebound in sales of its key drugs.

The company’s net income rose to $2.94 billion, or $1.16 per share, in the third quarter ended Sept. 30, from $1.90 billion, or $0.74 per share, a year earlier. (Reporting Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up